Used as a key chiral intermediate in the synthesis of biologically active pharmaceuticals, particularly in the development of fluorinated drug candidates targeting central nervous system disorders. Its structure enables enhanced metabolic stability and improved binding selectivity in receptor-targeted therapies. Commonly employed in asymmetric synthesis routes where the amine functionality serves as a handle for coupling reactions. The fluorinated aromatic moiety contributes to increased lipophilicity and membrane permeability, making it valuable in medicinal chemistry for optimizing pharmacokinetic properties.